Stroke Center University Hospital Basel
Basel, 4031, Switzerland
NCT Number: NCT02798770
Ischemic stroke is the leading cause of acquired disability among adults, and one of the main causes of death. In Switzerland, the approved time window for stroke treatment with intravenous thrombolysis after symptom onset is 4.5 h. Even within the 4.5 h time-window, however, the benefit of treatment strongly decreases as time passes.
Moreover, only around 10% patients receive thrombolytic treatment, since patients with stroke arrive too late to the hospital (prehospital delay). Despite efforts to educate the community on the symptom of stroke, prehospital delay did not decrease over time, and the reasons remain incompletely understood. Prehospital delay reduces the proportion of patients with ischemic stroke treated with thrombolysis, and reduces the odds of favorable outcome among the minority treated with thrombolysis.
This prospective cohort study aims at understanding the causes of prehospital delay among patients with acute ischemic stroke. Trained study-nurses will interview, at the bedside, patients and proxies along a standardized questionnaire on prehospital delay. Avoiding modificables causes of prehospital delay may increase the thrombolysis rate and improve outcomes after stroke.
Looking for future studies?
Notify Me17 year and older
All sexes
Observational
Basel, 4031, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: an average of 1 hour
Prehospital delay will be assessed by asking the Patient or witnesses how long the time interval between stroke onset and Hospital Admission is. For instance, if stroke symptoms have onset today at 3:00 PM and the Patient gets admitted today at 4:00 PM, prehospital delay is 1 hour.
University Hospital, Basel, Switzerland
Other
Reasons for Prehospital Delay in Patients With Acute Ischemic Stroke: a Prospective Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05953480
Acute Ischemic Stroke, Brain Diseases
Tucson, Arizona, United States
View Trial DetailsNCT05965687
Acute Ischemic Stroke, Brain Diseases
Beijing, China
View Trial DetailsNCT06101667
Acute Ischemic Stroke, Basilar Artery Occlusion
Beijing, Beijing Municipality, China
View Trial DetailsNCT06638151
Acute Ischemic Stroke, Brain Diseases
Edmonton, Alberta, Canada
View Trial Details